Research graph
References from Diagnostic performance of standardized prenatal ultrasound signs for predicting Hecht histopathological grade in placenta accreta spectrum: a retrospective study. Local targets link to admitted publications; unresolved targets remain external evidence.
Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging
10.1016/j.ajog.2017.05.067 · 2018 · External reference
Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease
10.1016/j.placenta.2011.11.010 · 2012 · External reference
New insights into the etiopathology of placenta accreta spectrum
10.1016/j.ajog.2022.02.038 · 2022 · External reference
Failure of placental detachment in accreta placentation is associated with excessive fibrinoid deposition at the utero-placental interface
10.1016/j.ajog.2021.08.026 · 2022 · External reference
FIGO placenta accreta diagnosis and management expert consensus panel. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening
10.1002/ijgo.12408 · 2018 · External reference
Placenta accreta and the risk of adverse maternal and neonatal outcomes
10.1515/jpm-2012-0219 · 2013 · External reference
Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis
10.1016/j.ajog.2019.01.233 · 2019 · External reference
Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel
10.1038/s41379-020-0569-1 · 2020 · External reference
Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis
10.1016/j.ajog.2017.02.050 · 2017 · External reference
International society for placenta accreta spectrum (IS-PAS). association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum: a multinational database study
10.1111/aogs.14103 · 2021 · External reference
Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa
10.1007/s00404-019-05338-y · 2019 · External reference
Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery
10.1002/uog.23100 · 2021 · External reference
Cesarean delivery and other uterine surgery as risk factors for placenta accreta: a systematic review and meta-analysis
10.1002/ijgo.12948 · 2019 · External reference
Association of implementing a multidisciplinary team approach in the management of morbidly adherent placenta with maternal morbidity and mortality
10.1097/aog.0000000000002865 · 2018 · External reference
FIGO placenta accreta diagnosis and management expert consensus panel. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening
10.1002/ijgo.12408 · ExternalCitation · doi-reference
Cesarean delivery and other uterine surgery as risk factors for placenta accreta: a systematic review and meta-analysis
10.1002/ijgo.12948 · ExternalCitation · doi-reference
Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery
10.1002/uog.23100 · ExternalCitation · doi-reference
Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa
10.1007/s00404-019-05338-y · ExternalCitation · doi-reference
Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis
10.1016/j.ajog.2017.02.050 · ExternalCitation · doi-reference
Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging
10.1016/j.ajog.2017.05.067 · ExternalCitation · doi-reference
Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis
10.1016/j.ajog.2019.01.233 · ExternalCitation · doi-reference
Failure of placental detachment in accreta placentation is associated with excessive fibrinoid deposition at the utero-placental interface
10.1016/j.ajog.2021.08.026 · ExternalCitation · doi-reference
New insights into the etiopathology of placenta accreta spectrum
10.1016/j.ajog.2022.02.038 · ExternalCitation · doi-reference
Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease
10.1016/j.placenta.2011.11.010 · ExternalCitation · doi-reference
Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel
10.1038/s41379-020-0569-1 · ExternalCitation · doi-reference
Association of implementing a multidisciplinary team approach in the management of morbidly adherent placenta with maternal morbidity and mortality
10.1097/aog.0000000000002865 · ExternalCitation · doi-reference
International society for placenta accreta spectrum (IS-PAS). association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum: a multinational database study
10.1111/aogs.14103 · ExternalCitation · doi-reference
Placenta accreta and the risk of adverse maternal and neonatal outcomes
10.1515/jpm-2012-0219 · ExternalCitation · doi-reference
